Category: Covid-19

Page 411«..1020..410411412413..420430..»

OHA reports over 1K new COVID-19 cases, decline in hospitalizations – KOIN.com

February 19, 2022

PORTLAND, Ore. (KOIN) The Oregon Health Authority reported 1,635 new confirmed and presumptive COVID-19 cases along with 12 COVID-related deaths in Fridays report.

This brings the states total case count to 685,953 and the states death toll to 6,456, OHA said.

Across the state, there are 741 patients hospitalized with COVID-19, a decrease of 47 people from Thursdays report. OHA noted that 126 COVID-19 patients are in intensive care unit beds, 21 fewer from Thursdays report.

OHA said there are 85 adult ICU beds available out of 682 and 280 adult non-ICU beds available out of 4,305.

Overall, theres 12% availability for adult ICU beds and 7% adult non-ICU beds available.

According to OHA, 3,149,702 people have had at least one COVID-19 vaccine dose, and 2,853,602 people have completed a COVID-19 vaccine series.

The seven-day running average is now 5,463 doses per day.

Cases by county

Baker (12), Benton (47), Clackamas (103), Clatsop (10), Columbia (21), Coos (29), Crook (12), Curry (8), Deschutes (90), Douglas (64), Harney (9), Hood River (15), Jackson (137), Jefferson (4), Josephine (32), Klamath (49), Lake (4), Lane (191), Lincoln (26), Linn (72), Malheur (10), Marion (137), Morrow (3), Multnomah (251), Polk (43), Sherman (1), Tillamook (16), Umatilla (31), Union (8), Wallowa (2), Wasco (10), Washington (163) and Yamhill (25)

Oregons 6,445th COVID-19-related death is a 95-year-old man from Union County who tested positive Feb. 5 and died Feb. 16 at Grande Ronde Hospital. Presence of underlying conditions is being confirmed.

Oregons 6,446th COVID-19-related death is an 88-year-old man from Multnomah County who tested positive Feb. 13 and died Feb. 13 at Adventist Health Portland. Presence of underlying conditions is being confirmed.

Oregons 6,447th COVID-19-related death is an 82-year-old man from Marion County who tested positive Feb. 12 and died Feb. 16 at Salem Hospital. He had underlying conditions.

Oregons 6,448th COVID-19-related death is a 50-year-old woman from Marion County who tested positive Feb. 11 and died Feb. 15 at Salem Hospital. She had underlying conditions.

Oregons 6,449th COVID-19-related death is an 88-year-old man from Lane County who tested positive Dec. 31, 2021, and died Jan. 13 at his residence. Presence of underlying conditions is being confirmed.

Oregons 6,450th COVID-19-related death is a 69-year-old man from Jackson County who tested positive Jan. 20 and died Feb. 16 at Providence Medford Medical Center. He had underlying conditions.

Oregons 6,451st COVID-19-related death is a 92-year-old man from Crook County who tested positive Jan. 25 and died Feb. 3 at his residence. He had underlying conditions.

Oregons 6,452nd COVID-19-related death is an 84-year-old man from Baker County who tested positive Feb. 1 and died Feb. 17 at Saint Alphonsus Medical Center Baker City. He had underlying conditions.

Oregons 6,453rd COVID-19-related death is an 87-year-old woman from Douglas County who tested positive Jan. 24 and died Feb. 11 at her residence. Presence of underlying conditions is being confirmed.

Oregons 6,454th COVID-19-related death is a 69-year-old man from Douglas County who tested positive Jan. 24 and died Jan. 24 at his residence. Presence of underlying conditions is being confirmed.

Oregons 6,455th COVID-19-related death is a 97-year-old woman from Yamhill County who tested positive Jan. 19 and died Feb. 13 at her residence. She had underlying conditions.

Oregons 6,456th COVID-19-related death is an 86-year-old woman from Washington County who tested positive Jan. 3 and died Feb. 10 at her residence. Presence of underlying conditions is being confirmed.

Read more here:

OHA reports over 1K new COVID-19 cases, decline in hospitalizations - KOIN.com

Youth First: Anxious kids in the age of Covid-19 – Washington Times Herald

February 19, 2022

When I started as a first year school social worker with years of experience in a clinical setting, I was surprised by how many kids were coming to my office with symptoms of anxiety.

Manifestations of anxiety can take on many forms. In addition to some children having physical symptoms that cant be attributed to a virus or illness, anxiety may also involve kids thinking upsetting thoughts and conjuring up wild what ifs.

To make matters worse, Ive met with several children who have lost a loved one due to COVID-19. Grief adds to the complexity of understanding the world around them.

Here are a few things both parents and school staff can utilize when faced with a student who is struggling with anxious thoughts.

1. Try belly breathing. Ask the student to place a hand on their chest and a hand on their belly. Tell them to expand their belly instead of their chest with each inhale. This teaches them how to take deep breaths which can physiologically calm the mind and body.

2. Use mindfulness techniques. This can look like praying with the child or asking them to name things they are thankful for (its hard to be worried when they can articulate their blessings). Ask them to clear their mind and just picture a blank space for as long as they are able.

3. Help them put their worries into perspective. Sometimes just stating what their worries are out loud and having a supportive person help them put things into perspective can provide reassurance.

4. Have open conversations. Let them know their concerns are valid and that you understand why they may be worried. Reassure them that its ok to talk about their worries. We do not want children to feel anxious about feeling anxious.

5. Name their worries. One term that Ive often heard used is the worry monster. Explain that this is a bully in our mind who is responsible for making them (and everyone else) think worrisome thoughts. When those thoughts come up, tell them to tell the worry monster to go away!

6. Make a list of coping activities. Listening to music, journaling, reading, physical activity, and getting outside are all great outlets that can help students minimize anxious thoughts.

7. Model and teach healthy behaviors. Children need to see their caregivers modeling healthy ways of managing worries and stress. They will learn from your example.

For the children I see, there are so many unknowns. Will school close again? Will I be cut off from family/friends? Will another important event be cancelled? Will I get sick? Will my loved ones get sick? Children are still often isolated with events being cancelled, quarantines, and some in-person activities taking place virtually. All these factors contribute to the increase in anxiety that mental health professionals are seeing.

This is not an argument for or against the restrictions put in place due to Covid-19, but an effort to raise awareness that the changes in our everyday lives are impacting our childrens mental health. Teaching children how to manage anxiety so it doesnt spiral out of control is an important part of nurturing a child. Hopefully the strategies above can help the next time you have a child struggling with anxiety.

We are making critical coverage of the coronavirus available for free. Please consider subscribing so we can continue to bring you the latest news and information on this developing story.

Kelly McClarnon, LCSW, is a Youth First Social Worker at Evansville Christian School in Warrick County. Youth First, Inc. is a nonprofit dedicated to strengthening youth and families. Youth First provides 78 Masters level social workers to 107 schools in 13 Indiana counties. Over 60,000 youth and families per year are served by Youth Firsts school social work and after school programs that prevent substance abuse, promote healthy behaviors, and maximize student success. To learn more about Youth First, visit youthfirstinc.org or call 812-421-8336.

See more here:

Youth First: Anxious kids in the age of Covid-19 - Washington Times Herald

Wisconsin Child Dies of Rare Condition Linked to COVID-19 – NBC Chicago

February 19, 2022

A Wisconsin child has died of a rare condition linked to COVID-19.

The Milwaukee Journal Sentinel reportedFriday the child is the first in the state to die of Multisystem Inflammatory Syndrome.

State health officials said the child died sometime within the last month. The child was under 10 years old and was from southeastern Wisconsin. Health officials declined to provide any further identifying details.

Tom Haupt, a state respiratory disease epidemiologist, says the child was one of 183 Wisconsin children who have contracted the disease. The U.S. Centers for Disease Control and Prevention had recorded 6,851 cases as of Jan. 31.

The syndrome appears two to six weeks after a child has been exposed to COVID-19. Symptoms include a lingering fever, chest pain and abdominal pain similar to appendicitis and a failure to stay awake. Greg Demuri, a pediatric infectious disease doctor with UW Health in Madison, said the disease can damage blood vessels and cause heart attacks. Doctors believe it affects Black and Hispanic children disproportionately.

The (children are) all universally very sick. They have fever, chest pain, vomiting, diarrhea, he said. The most significant component is a weakening of the heart muscle. Weve had to put a few children on heart medications.

See the article here:

Wisconsin Child Dies of Rare Condition Linked to COVID-19 - NBC Chicago

Ivermectin doesn’t prevent severe disease from Covid-19, new study finds – CNN

February 19, 2022

CNN

The antiparasitic drug ivermectin doesnt prevent severe disease from Covid-19 any more effectively than symptom management and close observation by medical professionals, according to a study published Friday in the journal JAMA Internal Medicine.

The study enrolled nearly 500 people 50 and older who were at risk of severe Covid-19 because of their age and underlying health. These patients were treated at 20 public hospitals and a quarantine center in Malaysia in 2021.

Half of the patients took a relatively high dose of oral ivermectin for five days, and the other half the comparison group received treatment for their symptoms, such as fever-reducing medications. All were monitored for progression of disease.

There was no difference in outcomes between the groups. In fact, slightly more patients in the ivermectin group went on to need extra oxygen compared with those who took a placebo, though the difference was not statistically significant.

This was the main outcome researchers studied, but they also looked at whether patients needed to be hospitalized, had to go on a ventilator, needed intensive care or died from their infections. There was no meaningful difference in outcomes between the group that took ivermectin and those who got the placebo treatment.

The study had several important strengths:

In addition to the fact that ivermectin didnt work, people who took it had more side effects than those who didnt, and sometimes those side effects were severe, including heart attacks, anemia and diarrhea that led to shock.

The higher incidence of side effects with ivermectin in our study raises concerns about the widespread use of this drug outside clinical trial setting, lead researcher Dr. Steven Lim told CNN in an email.

The public should understand that the highly touted safety profile of ivermectin is related to its use as an anti-parasitic drug. The use of ivermectin as an antiviral in COVID-19 is a totally different ball game, with notable differences in dosing, duration and mechanism of actions, wrote Lim, an infectious-disease specialist at Raja Permaisuri Bainun Hospital in Perak, Malaysia.

Two previous randomized-controlled trials of ivermectin for Covid-19, from Argentina and Colombia, concluded that there was no significant effect on symptoms or hospitalization rates, prompting the World Health Organization to advise that ivermectin be used to treat Covid-19 only within the setting of clinical trials.

Both the US Centers for Disease Control and Prevention and the US Food and Drug Administration have warned the public and prescribers not to use ivermectin to treat Covid-19.

See original here:

Ivermectin doesn't prevent severe disease from Covid-19, new study finds - CNN

Long COVID-19 sufferers in the Capital Region plead for treatment – Times Union

February 19, 2022

COLONIE It was Halloween 2020 when the first member of the Hogan family got sick.

First came excruciating headaches for Rebekah Hogan, a nurse at St. Peters Hospital in Albany. The cause was pretty obvious: Three days earlier, while waiting to get fit-tested for a new N-95 mask, she had prolonged close contact with a patient who would later test positive for coronavirus.

A test confirmed she was right, and one by one the illness swept through her family's Colonie home.

I was really sick by that Saturday night and by Sunday he was sick, she said of her husband, James. Then the kids started having symptoms.

Only one of the kids tested positive for coronavirus, but all three had similar symptoms around the same time, she said, including fevers, rashes, stomach pain and vomiting.

We were in pain, she said. And then, it just never seemed to end.

In the nearly 16 months since, the Hogans have experienced a wide range of symptoms they believe were caused by their infections, including headaches; fatigue; stomach, back and nerve pain; difficulty breathing; pounding heart; extreme exhaustion following exertion; and brain fog so severe that Rebekah quit her job and stopped driving for fear she would unintentionally harm herself or others.

In the beginning, they were saying, you know, six months, she said. And then at six months, they were saying this could last 12 to 18 months. And now I'm at what? Sixteen months? And they're like, you know, we might want to start talking about things you are capable of doing. To me, that felt like backpedal speak for, 'you probably arent getting better.'

The federal Centers for Disease Control and Prevention estimates that one in three people infected with coronavirus will develop long-term symptoms like the Hogans.

As the recent surge of infections declines, New York health officials and policymakers are turning their attention to this Post-Acute COVID-19 Syndrome more commonly called long COVID or long-haul COVID out of concern the omicron wave will lead to a sizable new population of patients with lingering health effects in need of treatment, support and disability accommodations.

"The fact is that they are never going to be able to accommodate the number of people who are suffering from long COVID," said Diana Berrent, founder of Survivor Corps, an advocacy group of over 200,000 members with current, chronic or past COVID-19. "Pre-omicron we had statisticians saying we had 150 million infections. That means 50 million cases of long COVID and that was before omicron."

At a Feb. 3 panel discussion hosted by the state Department of Health, doctors and researchers said not enough science is available yet to explain whether the less severe but highly transmissible omicron variant will produce long COVID symptoms similar to those caused by other variants. But they agreed the omicron wave is likely to produce a large influx of new "long haulers" due to the sheer number of infections it caused.

Research remains underway to determine exactly how and why coronavirus continues to cause so much damage over the long term for some people compared to others. But emerging science confirms the symptoms are very real and tied to the virus an important point for the people impacted, as many continue to face disbelief from friends, families and even doctors, experts in the area note.

Although we may not have a single unifying biomarker, that doesn't matter, said David Putrino, director of rehabilitation innovation with Mount Sinai Health System. We have enough evidence in the literature right now published that something is happening to the body to cause these changes, and so people should not be gaslit or told it's psychosomatic.

Much of the damage is believed to be triggered by an abnormal immune response that causes heightened, ongoing inflammation in the body that can wreak havoc on various body systems. Why some have this abnormal response is currently unclear, but researchers believe it may be genetic or caused by viral particles remaining in the body after infection.

When we're talking about long COVID, I want you to think about our members who are in their early 30s, who were athletes, who were, you know, marathon runners at the height of their career, who are now in wheelchairs, they are on permanent feeding tubes, they are disabled, Berrentsaid.

The CDCand other health authorities note that those who experienced mild or even no symptoms from their initial infection can go on to experience long COVIDsymptoms. Indeed, that's one reason health experts are not reassured by the reduced severity of omicron compared to other variants, since so many people have now been infected and may not even realize it.

When we looked into what the one symptom was that was most predictive of long COVID was it having a cough, was it having a fever? No," said Berrent. "It was being asymptomatic. So you have to remember that most of these people were not hospitalized. They had what are considered mild cases of COVID or asymptomatic cases, and they are largely the healthiest among us.

Panelists at the event earlier this month in Albany urged state policymakers to take a nation-leading role in the fight against long COVID like the state did in the fight against AIDS, citing New York's role as an early epicenter of both diseases.

Because of its complexity and impact to multiple body systems, health providers say long COVIDrequires a multidisciplinary response that includes primary care, cardiologists, pulmonologists, physical therapists, neuropsychiatrists and others.

Several large hospital systems and health care providers have convened and tapped multidisciplinary teams to lead and staff post-COVID care centers, but they still remain too few and more are needed, Berrentsaid.There are currently just 26 nationwide, including three in the Capital Region.

Dr. Amit Chopra, a pulmonologist with Albany Medical Center, said the hospital's post-COVID care center sees about 50 long COVIDpatients a month and has seen over 600 patients to date since opening roughly one year ago. Treating the physical symptoms is sometimes easier than treating the mental impact of the disease, he said.

"I think the biggest challenge we see is mental health issues afterwards," he said.

"If you do any testing and it comes back negative, people don't believe the patient has post-COVID ... and I think it just propagates and perpetuates the whole situation," he continued. "I think that's why we see a wide variety of symptoms that usually do include anxiety, depression and fatigue."

In addition to standing up more care centers, panelists urged the state Department of Health to identify certain well-performing centers as "centers of excellence" that could then consult via telehealth with primary care offices, federally qualified health centers and other ambulatory care settings. This is especially important to consider in the context of increasing access to long COVIDservices and supports, they said.

Dr. Monica Lypson, vice dean for education at Columbia University's Vagelos College of Physicians and Surgeons, began noticing inequities in access to long COVIDservices after helping to develop arecovery center at George Washington University.

"When we developed this clinic, one of the things that Istarted to realize was that the patient population that was seeking care at our clinic was the patient population that had commercial insurance, had excellent health care and could advocate in a way that others could not," she said.

Accessing long COVID services is already made difficult by the patient's symptoms, Putrino said.

If we don't have easy care navigation, if we don't have easy access to reimbursable, virtual care, and ... if we don't make it easy for people to get multidisciplinary tests in one sitting, we really are discriminating against people who are trying to protect their health by avoiding exertion, he said. And I think that that needs to be said over and over again. You know, I can categorically tell you as someone who's managed a lot of clinical care that access to care can be gated by symptoms of the people with long COVID. And so if we're not making every effort to make it easier, then that's exclusion.

The mental and emotional toll of long COVID will also require significant resources, panelists said.But the cost of not providing them would be even higher, they warned both to the individual and to society in the form of disability payouts, school accommodations, and higher costs to the health care system.

On an individual level,Berrentsaid Survivor Corps receives suicide threats daily from members experiencing long-term symptoms.

They might have their lives, but their livelihoods have been ripped from them, she said. And so this is more than just fatigue. This is more than just anxiety. These are lives that are ruined ... We have had many members actually take their own lives. So that is what we're talking about here. Thats not from depression. That's from having no hope for the future because their symptoms are so ravaging.

Hogan, who dreamed of becoming a nurse and buying a new house for her family, said she struggles to get out of bed and wonders if shell ever get back to the career she worked so hard for. Her husband, a disabled war veteran, battles depression. And their 9-year-old began having intrusive thoughts that his mother will die and refuses to leave her side.

In the meantime, the family has been working to enroll themselves in studies and see various doctors and specialists, but the ongoing fights with insurance companies and attempts to coordinate their own care have grown exhausting, Hogan said.

This is all stuff that is difficult for a healthy, neurotypical, able-bodied person. But we've got a disabled vet, and now I'm sick and I got three sick kids and it's like, 'Oh, my God, we need an adult in this house.' But there's no such thing. There's no such thing as sending in an adult to do the adult s---. So instead, you know, we try to scrape by, we try to do what we can. But like, it's not happening. Its not happening. And it's not fair. There's just nothing more you can do. I mean, what else is there to do?"

Read this article:

Long COVID-19 sufferers in the Capital Region plead for treatment - Times Union

Bill Gates: COVID-19 risks have reduced but next pandemic looms – Business Insider

February 19, 2022

Bill Gates has voiced his opinions on COVID-19 and future pandemics in a new interview.

Speaking to CNBC at Germany's annual Munich Security Conference on Friday, he said the danger of experiencing severe disease from COVID-19 has "dramatically reduced."

"The chance of severe disease, which is mainly associated with being elderly and having obesity or diabetes , those risks are now dramatically reduced because of that infection exposure," he said.

He added, however, that he believes the world will see another pandemic.

"We'll have another pandemic. It will be a different pathogen next time," Gates said, per CNBC.

But the Microsoft cofounder said he thought that if there was a rational response then "we'll catch it early" and it "won't go global like it did this time."

In terms of whether it is possible to prevent another pandemic altogether, Gates told CNBC's Hadley Gamble: "If every country did what Australia did, then you wouldn't be calling it a pandemic."

Gates has become a prominent figure in the fight against COVID-19 by pledging billions to response efforts.

Before COVID-19 emerged, he predicted the world would suffer from a pandemic, along with notable disease and flu experts.

In a2015 TED talk, Gates said the world was "not ready for the next epidemic."

This month, the billionaire announced that his new book will explore his views on how to prevent the next pandemic.

It will also discuss how he became the subject onlineconspiracy theories, which claimed that he was exploiting the vaccines to implant microchips in people.

More:

Bill Gates: COVID-19 risks have reduced but next pandemic looms - Business Insider

Covid-19 in Africa: ‘The doses are here, but vaccine hesitancy remains high’ – FRANCE 24 English

February 19, 2022

Issued on: 19/02/2022 - 14:30

The World Health Organisation (WHO) announced on Friday the launch of a Covid-19 vaccine production programme in Africa. Six countries (South Africa, Egypt, Kenya, Nigeria, Senegal and Tunisia) will be equipped with production lines to manufacture doses of mRNA vaccines, in an initiative aimed at reducing the continents reliance on vaccine imports and boosting low immunisation rates.

FRANCE 24 spoke to Professor Yap Boum, representative of Epicentre, the research arm of Doctors Without Borders, about the evolution of the pandemic on the continent.

A strong advocate for vaccine equality, the UN organisation is concerned about the slow deployment of jabs on the African continent, where only 11.3% of the population is fully vaccinated despite a considerable increase in doses in recent months.

"Vaccination rates must increase sixfold if the continent is to reach the 70% coverage target set for the end of the first semester of 2022," the WHO warned in early February.

FRANCE 24 spoke to Professor Yap Boum, representative of Epicentre, the research arm of Doctors Without Borders, about the evolution of the pandemic in Africa and the continents vaccine rollout.

FRANCE 24: The announcement of this vaccine production programme against Covid-19 has been hailed as an "event of historic importance" by Kenyan President Uhuru Kenyatta. Do you share his enthusiasm?

Yap Boum: This is indeed a very important announcement in many ways. The Covid-19 pandemic has exposed Africa's over-reliance on global health supplies, with 98% of its vaccines coming from abroad. In this context, Africa, at the mercy of donor goodwill and external production imperatives, has experienced delays in immunising its population. We sawthis when India was hit by a sudden Covid-19 outbreak and had to curtail its exports of the AstraZeneca vaccine through the Covax programme [Editors note: which provided jabs to many African countries].

The vaccine production programme announced by the WHO is a giant step forward in that vaccines can now be manufactured according to need, providing an appropriate response to local situations.

This initiative will also boost research on the continent, allowing Africa to participate in the global effort to develop better vaccines to put an end to the pandemic and not just to slow it down and prevent severe forms, as is currently the case. On the research front, this programme will also enable clinical trials to be conducted in Africa. This point is crucial, as the effectiveness of vaccines can vary depending on context and populations. So far, only one study has been conducted on the continent, by AstraZeneca in South Africa.

Since the beginning of the pandemic, the WHO has been working hard to provide better access to Covid-19 vaccines. Yet, despite improved supply, vaccine uptake in Africa remains low. Why is this so?

First, we must acknowledge that WHO President Tedros Adhanom Ghebreyesus and Africa CDC President John Nkengasong have done a remarkable job of lobbying for these vaccines. But supply is only one part of the problem. Today, the doses are here, but vaccine hesitancy remains high. This is partly due to misinformation, but also and above all to the health situation in most African countries where, despite high rates of contamination comparable to Europe, deaths have remained much lower.

For example, Cameroon has recorded only 2,000 Covid-19-related deaths since the start of the pandemic. While this figure does not include those who have died within local communities, it is still far lower than what has been observed in European countries. Of course, not all African countries are in the same boat: Morocco, Algeria and South Africa have been more severely affected. But the low vaccination rate is based on a simple logic: the less risk people perceive, the less they feel the need to get vaccinated.

The WHO has called on African countries to accelerate their vaccine rollouts. Are there still logistical problems impeding access to vaccines? What about awareness campaigns?

Today's vaccination campaigns are heavily focused on cities, and it is sometimes difficult to get doses to more remote areas. This is a problem of financing but also of logistical organisation, which is sometimes difficult to put in place in isolated areas with poorly developed infrastructure.

To raise awareness around vaccination, governments need to focus on targeted campaigns and set the right priorities. The role of the WHO is to set continental targets, but these rules must then be adapted to each countrys specific situation in order to be relevant. For example, Niger, where 50% of the population is underage, will not be able to reach the 70% target unless it vaccinates children en masse which is clearly not the priority at the moment.

In Cameroon, only 7.9% of the elderly and 6.2% of people with pre-existing conditions have received at least one dose. On average, the vaccination rate among vulnerable groups is even lower than that of the general population (7.8%). Therefore, there is an urgent need to focus vaccination efforts on these groups, which account for the bulk of Covid-19-related deaths.

This article has been translated fromthe original in French.

See the original post:

Covid-19 in Africa: 'The doses are here, but vaccine hesitancy remains high' - FRANCE 24 English

COVID-19 Isnt Going Anywhere And Americans Know It – FiveThirtyEight

February 19, 2022

The idea that Americans are tired of the pandemic has become conventional wisdom, with important policy implications. Democratic governors in blue states like New Jersey and California have rolled back mask mandates, citing the importance of normalcy. But is normal what Americans really expect? And what does normal even mean, anyway?

A recent Monmouth University poll found that 70 percent of Americans agreed with the statement, Its time we accept that Covid is here to stay and we just need to get on with our lives. This poll got a lot of attention it was featured in The New York Times, The Hill and other outlets, and was even discussed in a recent episode of FiveThirtyEights Politics podcast. Its not an outlier, either. A Feb. 11-13 poll from Harris found that 71 percent of Americans agreed with the statement, We will be living with COVID in some form forever.

At this point, most Americans believe COVID-19 will persist into the near (or distant) future, but what that means to peoples daily lives is the subject of much more dissent. Thats because understanding COVID-19 as an ongoing reality means something different to everyone.

For some, it means going back to pre-pandemic life, without mask mandates, vaccine requirements or other public health measures to contain the spread of the virus. But thats not what it means to most, according to a Feb. 4-7 Axios/Ipsos poll, in which just 21 percent of Americans said we should get back to life as usual with no coronavirus mandates or requirements. To be sure, 29 percent thought we should move toward that goal with some precautions, while 23 percent wanted to mostly keep precautions in place and 21 percent wanted to increase precautions. Part of the reason opinion is so divided is that Americans are simultaneously ready and not-ready to go back to pre-pandemic life. Over three-quarters of Americans said they were ready to return to normal, according to a Feb. 12-15 poll from The Economist/YouGov. And yet the Axios/Ipsos poll showed that 54 percent thought doing so posed a large or moderate risk.

What Americans want regarding COVID-19 is all over the place. And theres only so much the polls can tell you. For instance, they cant list every public health response to COVID-19, much less every combination of responses. But polls show that support is shifting more toward individual precautions than toward COVID-19 protections mandated for society at large.

And Americans seem to be OK with being more cautious in their personal decisions. That is, theyre more willing to undergo measures like mask-wearing or vaccinations for themselves, though they may not want to institute it as a requirement. According to a Jan. 24-30 poll from the Pew Research Center, 73 percent of Americans were fully vaccinated, but just 58 percent supported requiring proof of vaccination to fly. And Americans were even less supportive of requiring vaccines for the four other activities Pew asked about attending a sporting event or concert (53 percent), going to college in-person (52 percent), eating inside a restaurant (46 percent) and shopping inside a store (40 percent). In fact, overall support for vaccine mandates may be declining. Americans were 3 to 5 percentage points more supportive of requiring vaccines for these activities when Pew polled about this in August 2021.

Support for mask mandates is mixed. In the aforementioned Harris poll, 55 percent of Americans strongly or somewhat agreed that it was time to lift indoor mask mandates. But the Monmouth poll found that 52 percent supported statewide mask and social-distancing guidelines, though this figure is down from 55 percent in December and from 63 percent in September. Likewise, according to Axios/Ipsos, support for local and statewide mask mandates in all public places tended to fluctuate inside a somewhat narrow range of 60 percent to 67 percent, with the greatest support roughly correlated to the peaks of the delta and omicron waves. But one thing is clear: Even if Americans are backing mask mandates less, most still say they would wear a mask indoors. The Harris poll also found that 69 percent of Americans were at least somewhat likely to keep wearing masks indoors now that indoor mask mandates were being lifted, and for those living in places with mask mandates, 58 percent said they would continue to occasionally mask up once those requirements were removed, according to The Economist/YouGov.

One reason support for vaccine and mask mandates may be falling is that the public simply doesnt trust the government to handle the pandemic correctly. Approval ratings for hospitals and medical centers responses to COVID-19 were still very high, according to Pew, but approval ratings for President Biden, public health officials and elected officials in state and local governments all declined by double digits since March 2020. In fact, Pew found a significant decline in the approval rating for state elected officials, from a high of 70 percent in March 2020 to a low of 46 percent in January 2022. This may be why governors in particular are pushing for a return to normal.

Pew also found that shifting public health guidelines have led to an increasing share of Americans who feel confused or less confident in public officials recommendations. They also just trust public health officials less than they used to. After almost two years of dealing with the pandemic, Americans may trust their own decision-making more than guidance from the government.

Gone, too, are the days of declaring a full-scale wartime effort until the virus is vanquished. Instead, theres more acceptance among Americans that the pandemic is probably here to stay in some form. What this means, though, has been the subject of so much debate that its unsurprising that so many Americans are uncertain about what actions should be taken on a broader scale to address the pandemic. Regulating their individual actions and expressing their discontent may really be the only thing under their control.

According to FiveThirtyEights presidential approval tracker, 41.4 percent of Americans approve of the job Biden is doing as president, while 53.0 percent disapprove (a net approval rating of -11.6 points). At this time last week, 41.3 percent approved and 52.6 percent disapproved (a net approval rating of -11.3 points). One month ago, Biden had an approval rating of 42.5 percent and a disapproval rating of 52.1 percent, for a net approval rating of -9.6 points.

In our average of polls of the generic congressional ballot, Republicans currently lead by 2.1 percentage points (44.8 percent to 42.6 percent). A week ago, Republicans led Democrats by 2.0 points (44.5 percent to 42.6 percent). At this time last month, voters preferred Republicans by 0.6 points (42.4 percent to 41.8 percent).

Original post:

COVID-19 Isnt Going Anywhere And Americans Know It - FiveThirtyEight

Northeastern to End Required COVID-19 Testing – News@Northeastern

February 19, 2022

In a move that signals the next phase of COVID-19 management, Northeastern University is ending its required weekly surveillance testing at the end of the month and instead moving to optional weekly testing for asymptomatic individuals.

Along with the shift, members of the Northeastern community will no longer need to complete daily wellness checks before going to campus; instead, the checks will be required only when arriving for a COVID-19 test. Testing will still be required for people experiencing symptoms. The change goes into effect on Monday, Feb. 28, at which point the university will also discontinue use of its COVID-19 dashboard.

We will continue to monitor developments and adapt our approach as needed, university officials wrote in a statement. From the very beginning of the pandemic, our community of faculty, staff, students, and others joined together to become a model of flexibility, resilience, and mutual support.

Northeastern has been testing all students, faculty, and staff for COVID-19 since mid-August 2020. Blanket surveillance testing, as it is known, of the entire community was a highly effective strategy to identify pockets of positive cases and isolate those individuals from the rest of the university population before they could infect others.

The robust testing system, which included the creation of an in-house testing labthe Life Sciences Testing Center in Burlington, Massachusettsenabled Northeastern to safely bring students, faculty, and staff back to campus for the 2020 fall semester.

In the nearly two years since then, however, the COVID-19 landscape has changed dramatically, both on the universitys campuses and around the world. The U.S. has made tremendous progress in its ability to protect against the virus, White House coronavirus response coordinator Jeff Zients said Wednesday. The country is moving toward a time when COVID isnt a crisis, but something we can protect against and treat, he said.

Northeasterns shift away from required surveillance testing is a marked step toward a new normal that includes living with the virusone that received mixed reviews from students interviewed about the policy change.

Sam Block, a second-year student of computer science, says he supported the change, and that COVID-19 has faded into something that isnt too big of a worry anymore.

On the other hand, Arya Venkat, a first-year student of economics, says that the mandatory surveillance testing offered her peace of mind in a younger population where infection doesnt always come with symptoms. Still, she says shes open-minded about relaxing various restrictions as public-health guidance dictates.

Jared Auclair, who is an associate teaching professor of chemistry and chemical biology at Northeastern and runs the universitys COVID-19 testing facility, says the change is a logical step.

As we transition to the next stage of the pandemic within the university, were not taking testing away. Were just saying that we are no longer doing asymptomatic surveillance testing, he says. Symptomatic people should still test. And testing is optional for anybody else who feels like they need to get a test.

Were not turning it off, Auclair says. Were just moving to a place where its optional if you dont have symptoms, and if you have symptoms you have to get tested. And I think thats a logical step.

Indeed, there are a lot more tools in the pandemic toolbox than there were two years ago. Now, vaccines against SARS-CoV-2, the virus that causes COVID-19, are widely available in the United States and many other parts of the worldand Northeastern requires all students, faculty, and staff at its North American campuses to be fully vaccinated. Additionally, doctors have treatments that they can use to reduce the risk of an infection becoming fatal, and the virus itself seems to be mutating in a way that makes it less severe (albeit more infectious).

University officials are evaluating mask requirements for all of Northeasterns campuses, as welldecisions that are informed by local public health guidance. The City of Boston has yet to lift its indoor mask requirements. At other campus locations, including Nahant and Burlington in Massachusetts, London, and the San Francisco Bay Area, indoor mask requirements already have been lifted, and indoor mask-wearing is optional at those sites.

For media inquiries, please contact media@northeastern.edu.

Excerpt from:

Northeastern to End Required COVID-19 Testing - News@Northeastern

Biden to extend U.S. national emergency due to COVID-19 health risk – Reuters

February 19, 2022

U.S. President Joe Biden delivers remarks on his administration's efforts to pursue deterrence and diplomacy in response to Russias military buildup on the border of Ukraine, from the White House in Washington, U.S., February 18, 2022. REUTERS/Kevin Lamarque

Register

Feb 18 (Reuters) - President Joe Biden said on Friday the U.S. national emergency declared in March 2020 due to the COVID-19 pandemic will be extended beyond March 1 due to the ongoing risk to public health posed by the coronavirus.

Biden said the deaths of more than 900,000 Americans from COVID-19 emphasized the need to respond to the pandemic with "the full capacity" of the federal government.

Former President Donald Trump had declared a national emergency almost two years ago to free up $50 billion in federal aid.

Register

"There remains a need to continue this national emergency," Biden said in a letter on Friday to the speaker of the House of Representatives and the president of the Senate.

The letter was released by the White House.

The emergency would have been automatically terminated unless, within 90 days prior to the anniversary date of its declaration, the president sent a notice to the Congress stating it is to continue beyond the anniversary date.

Biden's step to extend the emergency comes even as a slew of local leaders in the United States are dialing back pandemic restrictions as the Omicron wave ebbs. read more

The governors of New York and Massachusetts announced last week that they would end certain mask mandates in their states, following similar moves by New Jersey, California, Connecticut, Delaware and Oregon.

U.S. health officials said earlier this week they were preparing for the next phase of the pandemic as Omicron-related cases decline. read more

Register

Reporting by Kanishka Singh in Bengaluru; Editing by Will Dunham and Sandra Maler

Our Standards: The Thomson Reuters Trust Principles.

Read this article:

Biden to extend U.S. national emergency due to COVID-19 health risk - Reuters

Page 411«..1020..410411412413..420430..»